PetIQ Inc (PETQ)
17.04
+0.20
(+1.19%)
USD |
NASDAQ |
May 03, 16:00
17.02
-0.02
(-0.09%)
After-Hours: 20:00
PetIQ Revenue (Quarterly): 219.93M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 219.93M |
| September 30, 2023 | 277.02M |
| June 30, 2023 | 314.55M |
| March 31, 2023 | 290.47M |
| December 31, 2022 | 184.08M |
| September 30, 2022 | 209.72M |
| June 30, 2022 | 252.01M |
| March 31, 2022 | 275.70M |
| December 31, 2021 | 196.64M |
| September 30, 2021 | 210.53M |
| June 30, 2021 | 271.01M |
| March 31, 2021 | 254.35M |
| December 31, 2020 | 164.21M |
| September 30, 2020 | 162.08M |
| June 30, 2020 | 266.98M |
| March 31, 2020 | 186.78M |
| Date | Value |
|---|---|
| December 31, 2019 | 154.34M |
| September 30, 2019 | 186.02M |
| June 30, 2019 | 220.63M |
| March 31, 2019 | 148.44M |
| December 31, 2018 | 111.02M |
| September 30, 2018 | 131.38M |
| June 30, 2018 | 171.14M |
| March 31, 2018 | 115.07M |
| December 31, 2017 | 51.93M |
| September 30, 2017 | 60.55M |
| June 30, 2017 | 87.18M |
| March 31, 2017 | 67.03M |
| December 31, 2016 | 44.91M |
| September 30, 2016 | 41.67M |
| June 30, 2016 | 61.28M |
| March 31, 2016 | 52.30M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
154.34M
Minimum
Dec 2019
314.55M
Maximum
Jun 2023
226.16M
Average
219.93M
Median
Dec 2023
Revenue (Quarterly) Benchmarks
| Dynavax Technologies Corp | 55.60M |
| Pacira BioSciences Inc | 181.24M |
| Supernus Pharmaceuticals Inc | 164.31M |
| Esperion Therapeutics Inc | 32.25M |
| Deciphera Pharmaceuticals Inc | 48.29M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.49M |
| Total Expenses (Quarterly) | 218.66M |
| EPS Diluted (Quarterly) | -0.60 |
| Enterprise Value | 829.40M |
| Gross Profit Margin (Quarterly) | 20.00% |
| Profit Margin (Quarterly) | -7.95% |
| Earnings Yield | 0.35% |
| Operating Earnings Yield | 10.67% |
| Normalized Earnings Yield | 3.418 |